Oral Everolimus for Treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate—Rapid Tumor Regression Documented by Real Time 3D Echocardiography
- 22 July 2015
- journal article
- case report
- Published by Wiley in Echocardiography
- Vol. 32 (12) , 1876-1879
Abstract
The presented case reports on successful treatment with everolimus in a neonate with left ventricular giant rhabdomyoma. The authors used a different dosage regime compared to literature and documented rapid tumor regression by 3D echocardiography.Keywords
This publication has 10 references indexed in Scilit:
- Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defectBMJ Case Reports, 2014
- Regression of Symptomatic Multiple Cardiac Rhabdomyomas Associated with Tuberous Sclerosis Complex in a Newborn Receiving EverolimusJournal of Tropical Pediatrics, 2014
- Rapid Regression of Left Ventricular Outflow Tract Rhabdomyoma After Sirolimus TherapyPediatrics, 2014
- The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanentPediatric Nephrology, 2014
- Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimusUltrasound in Obstetrics & Gynecology, 2014
- Everolimus: A Challenging Drug in the Treatment of Multifocal Inoperable Cardiac RhabdomyomaPediatrics, 2012
- Regression of a Cardiac Rhabdomyoma in a Patient Receiving EverolimusPediatrics, 2011
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous SclerosisNew England Journal of Medicine, 2010
- Tuberous sclerosisThe Lancet, 2008
- Cardiac Rhabdomyoma in a Neonate: Application of Serial EchocardiographyEchocardiography, 2006